- Home
- DXR vs APYX Comparison
DXR vs APYX Comparison
Compare DXR & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- APYX
- Stock Information
- Founded
- DXR 1970
- APYX 1982
- Country
- DXR United States
- APYX United States
- Employees
- DXR N/A
- APYX N/A
- Industry
- DXR Medical/Dental Instruments
- APYX Medical/Dental Instruments
- Sector
- DXR Health Care
- APYX Health Care
- Exchange
- DXR Nasdaq
- APYX Nasdaq
- Market Cap
- DXR 42.6M
- APYX 42.3M
- IPO Year
- DXR N/A
- APYX 1987
- Fundamental
- Price
- DXR $8.24
- APYX $1.57
- Analyst Decision
- DXR Strong Buy
- APYX Hold
- Analyst Count
- DXR 1
- APYX 2
- Target Price
- DXR $24.75
- APYX N/A
- AVG Volume (30 Days)
- DXR 23.0K
- APYX 71.3K
- Earning Date
- DXR 01-01-0001
- APYX 11-08-2024
- Dividend Yield
- DXR N/A
- APYX N/A
- EPS Growth
- DXR N/A
- APYX N/A
- EPS
- DXR 0.35
- APYX N/A
- Revenue
- DXR $154,205.00
- APYX $48,542,000.00
- Revenue This Year
- DXR N/A
- APYX N/A
- Revenue Next Year
- DXR N/A
- APYX $2.78
- P/E Ratio
- DXR $23.96
- APYX N/A
- Revenue Growth
- DXR N/A
- APYX N/A
- 52 Week Low
- DXR $7.19
- APYX $0.97
- 52 Week High
- DXR $10.04
- APYX $2.80
- Technical
- Relative Strength Index (RSI)
- DXR 40.06
- APYX 50.85
- Support Level
- DXR $8.04
- APYX $1.46
- Resistance Level
- DXR $8.42
- APYX $1.72
- Average True Range (ATR)
- DXR 0.36
- APYX 0.20
- MACD
- DXR -0.09
- APYX -0.03
- Stochastic Oscillator
- DXR 14.47
- APYX 30.91
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.